Patseas, Dimitrios
El-Masry, Ahmed
Liu, Zuobin
Ramachandran, Prakash
Triantafyllou, Evangelos https://orcid.org/0000-0002-2755-9619
Funding for this research was provided by:
RCUK | Medical Research Council (MR/X009904/1)
RCUK | Medical Research Council (MR/W015919/1)
Article History
Received: 27 March 2025
Revised: 26 June 2025
Accepted: 27 June 2025
First Online: 28 July 2025
Competing interests
: PR has served as a consultant for Merck and Macomics and has received research grant funding from Genentech and Intercept.